These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17035666)

  • 21. Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice.
    Ansonoff MA; Zhang J; Czyzyk T; Rothman RB; Stewart J; Xu H; Zjwiony J; Siebert DJ; Yang F; Roth BL; Pintar JE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):641-8. PubMed ID: 16672569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.
    Harding WW; Tidgewell K; Byrd N; Cobb H; Dersch CM; Butelman ER; Rothman RB; Prisinzano TE
    J Med Chem; 2005 Jul; 48(15):4765-71. PubMed ID: 16033256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors.
    Simpson DS; Lovell KM; Lozama A; Han N; Day VW; Dersch CM; Rothman RB; Prisinzano TE
    Org Biomol Chem; 2009 Sep; 7(18):3748-56. PubMed ID: 19707679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: selective modification of the furan ring.
    Harding WW; Schmidt M; Tidgewell K; Kannan P; Holden KG; Dersch CM; Rothman RB; Prisinzano TE
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3170-4. PubMed ID: 16621556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland.
    Giroud C; Felber F; Augsburger M; Horisberger B; Rivier L; Mangin P
    Forensic Sci Int; 2000 Aug; 112(2-3):143-50. PubMed ID: 10940599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.
    Capasso R; Borrelli F; Cascio MG; Aviello G; Huben K; Zjawiony JK; Marini P; Romano B; Di Marzo V; Capasso F; Izzo AA
    Br J Pharmacol; 2008 Nov; 155(5):681-9. PubMed ID: 18622408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biosynthesis of the psychotropic plant diterpene salvinorin A: Discovery and characterization of the Salvia divinorum clerodienyl diphosphate synthase.
    Pelot KA; Mitchell R; Kwon M; Hagelthorn LM; Wardman JF; Chiang A; Bohlmann J; Ro DK; Zerbe P
    Plant J; 2017 Mar; 89(5):885-897. PubMed ID: 27865008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the psychoactive terpenoid salvinorin A content in five Salvia divinorum herbal products.
    Wolowich WR; Perkins AM; Cienki JJ
    Pharmacotherapy; 2006 Sep; 26(9):1268-72. PubMed ID: 16945049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical investigation of legal high products containing Salvia divinorum traded in smartshops and internet.
    Xavier Moreira F; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
    Forensic Sci Int; 2014 Sep; 242():255-260. PubMed ID: 25093918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical syntheses of the salvinorin chemotype of KOR agonist.
    Hill SJ; Brion AUCM; Shenvi RA
    Nat Prod Rep; 2020 Nov; 37(11):1478-1496. PubMed ID: 32808003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From local to global-fifty years of research on Salvia divinorum.
    Casselman I; Nock CJ; Wohlmuth H; Weatherby RP; Heinrich M
    J Ethnopharmacol; 2014 Feb; 151(2):768-83. PubMed ID: 24315983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total synthesis of the hallucinogenic neoclerodane diterpenoid salvinorin A.
    Nozawa M; Suka Y; Hoshi T; Suzuki T; Hagiwara H
    Org Lett; 2008 Apr; 10(7):1365-8. PubMed ID: 18311991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neo-clerodane diterpenes from the hallucinogenic sage Salvia divinorum.
    Shirota O; Nagamatsu K; Sekita S
    J Nat Prod; 2006 Dec; 69(12):1782-6. PubMed ID: 17190459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvia divinorum and salvinorin A: an update on pharmacology and analytical methodology.
    Grundmann O; Phipps SM; Zadezensky I; Butterweck V
    Planta Med; 2007 Aug; 73(10):1039-46. PubMed ID: 17628834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to kappa-opioid receptors.
    Yan F; Mosier PD; Westkaemper RB; Stewart J; Zjawiony JK; Vortherms TA; Sheffler DJ; Roth BL
    Biochemistry; 2005 Jun; 44(24):8643-51. PubMed ID: 15952771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A.
    Valdés LJ
    J Psychoactive Drugs; 1994; 26(3):277-83. PubMed ID: 7844657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective natural kappa opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction.
    Fichna J; Schicho R; Janecka A; Zjawiony JK; Storr M
    Drug News Perspect; 2009 Sep; 22(7):383-92. PubMed ID: 19890495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvia divinorum use and phenomenology: results from an online survey.
    Sumnall HR; Measham F; Brandt SD; Cole JC
    J Psychopharmacol; 2011 Nov; 25(11):1496-507. PubMed ID: 20937616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.
    Munro TA; Rizzacasa MA; Roth BL; Toth BA; Yan F
    J Med Chem; 2005 Jan; 48(2):345-8. PubMed ID: 15658846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization of salvinorin A and related compounds in glandular trichomes of the psychoactive sage, Salvia divinorum.
    Siebert DJ
    Ann Bot; 2004 Jun; 93(6):763-71. PubMed ID: 15087301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.